Skip to ContentSkip to Navigation
About us Latest news News News articles

Personalized pharmacotherapy of psychosis clinical and pharmacogenetic approaches

08 June 2011

PhD ceremony: Mr. J. Vehof, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Personalized pharmacotherapy of psychosis clinical and pharmacogenetic approaches

Promotor(s): prof. H. Snieder, prof. R.P. Stolk

Faculty: Medical Sciences

 

Despite 60 years of antipsychotic drugs, the pharmacotherapy of psychosis is still far from ideal. In particular side-effects, such as weight gain and therapy induced movement disorders, are major problems. The aim of this thesis is to contribute to the development of personalised medicine for the treatment of psychosis through the study of clinical factors in the use of oral and depot antipsychotic drugs, and the pharmacogenetics of antipsychotic response and drug-induced side effects. Several clinical factors were determined that predict which patients switch form oral to depot treatment, including the presence of movement disorders, lack of compliance, and lack of psychiatric co-morbidity. New associations were found between various polymorphisms in receptor genes and metabolic disturbances and movement disorders in patients on antipsychotic medication. The researchers were not able to replicate several associations of polymorphisms that were found in earlier studies. Negative results and lack of replication are common in pharmcogenetic studies of antipsychotic drugs. There is growing evidence that environmental, ethnic and many other factors affect the link between genetic variation and the efficacy of antipsychotic drugs.

  

Last modified:13 March 2020 01.12 a.m.
View this page in: Nederlands

More news

  • 15 May 2024

    Part of the children with ADHD can stop using Ritalin sooner

    A part of children with ADHD could stop taking Ritalin after two years. This is the conclusion of Anne-Flore Matthijssen's PhD research.

  • 13 May 2024

    Trapping molecules

    In his laboratory, physicist Steven Hoekstra is building an experimental set-up made of two parts: one that produces barium fluoride molecules, and a second part that traps the molecules and brings them to an almost complete standstill so they can...

  • 06 May 2024

    Impact: 'URinControl', treatment of urine loss through app

    One of the three researchers nominated for the Ben Feringa Impact Award 2024 is general practicioner and researcher-epidemiologist Anne Loohuis. Loohuis conducted research on the treatment of urine loss through the self-help app URinControl'.